RecruitingNCT06697964

High Resolution Anuscopy Study


Sponsor

Universitair Ziekenhuis Brussel

Enrollment

500 participants

Start Date

Aug 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillomavirus (HR HPV). HRA referral is recommended for individuals with abnormal cytology. HRA represents the only method to identify precancerous lesions of the anal canal, with only few specialists knowledgeable about it. At UZ Brussel, the investigators collected a wealth of data about HPV infection and its association with anal pathology. By establishing a comprehensive study, the investigators can delve into this data with specific research questions, conducting valuable research to provide answers to pressing clinical questions and contribute to advancements in medical understanding and treatment.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data from patients who have had or will have a high-resolution anoscopy (HRA) — a detailed examination of the anal canal used to detect abnormal cells or lesions that could lead to anal cancer. **You may be eligible if...** - You have already had an HRA at UZ Brussel hospital, or you are being referred for one in the future - You are 18 years or older - You can understand and communicate in French, Dutch, or English **You may NOT be eligible if...** - There are no exclusion criteria for this study — nearly everyone referred for HRA may be eligible Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHRA

High resolution anoscopy to help evaluate anal conditions such as precancerous lesions


Locations(1)

UZ Brussel

Jette, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06697964


Related Trials